Stockreport

Innate Pharma's stock rallies 23% on leukemia drug submission in Europe [MarketWatch]

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF Innate Pharma's stock rallies 23% on leukemia drug submission in Europe Shares of Innate Pharma SA IPHA, +22.20% gained 23% in premarket trading on Thursday after the [Read more]